)
Visual
earnings real time
Achieve Life Sciences
Achieve Life Sciences (ACHV) investor relations material
Achieve Life Sciences Registration Filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Registration Filing summary23 Jan, 2026
Company overview and business model
Focuses on addressing nicotine dependence through development and commercialization of cytisinicline, targeting both combustible cigarette and e-cigarette users in the U.S. and globally.
Operates as a late-stage clinical specialty pharmaceutical company with a mission to reduce preventable deaths from tobacco use.
Principal executive offices are located in Bothell, WA, and Vancouver, BC.
Financial performance and metrics
As of September 30, 2025, 52,812,488 shares of common stock were issued and outstanding, with no preferred stock outstanding.
33,955,958 warrants outstanding with a weighted-average exercise price of $3.92 per share; 142,857 pre-funded warrants at $0.001 per share.
5,274,182 shares reserved for stock-based compensation plans, including options and restricted stock units.
Use of proceeds and capital allocation
Net proceeds from securities sales will be used for general corporate purposes, including research, clinical and process development, manufacturing, commercialization, working capital, debt reduction, acquisitions, investments, and capital expenditures.
Pending use, proceeds may be invested in short- or long-term investment-grade, interest-bearing securities.
Cytisinicline market potential?
Strategy for $300M shelf offering?
Potential dilution from outstanding warrants?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Latest summaries
- TimeTickerHeadlineOpen
- 9101
Profits fell across most segments, but energy shipping and a major acquisition stood out. - 4626
Double-digit profit and sales growth, with strong segment results and a stock split impact. - 323410
Strong growth in customers, profits, and deposits, with stable asset quality and global expansion. - 2371
Revenue up 21.5% YoY, but profit down on higher investments; LiPLUS Holdings acquired. - 3401
Major impairments and divestitures led to a net loss and lower revenue across all segments. - RYM
Refreshed strategy targets NZD 150m cash flow uplift, NZD 500m release, and resumed dividends by FY 2028. - 8002
Profit forecast raised to ¥540.0B and annual dividend to ¥107.50 per share after strong results. - COF
Profit rebounded, NTA and occupancy rose, with strong leasing and premium divestment. - NUF
Statutory loss reported, seeds business repositioned, new CEO appointed, all resolutions passed. - 8303
Profit and comprehensive income surged, with public funds fully repaid and TSE Prime listing completed.
Next Achieve Life Sciences earnings date
Q4 202513 Mar, 2026
Achieve Life Sciences
Next Achieve Life Sciences earnings date
Q4 202513 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
)
Frequently asked questions
Achieve Life Sciences, Inc. is a biopharmaceutical company focused on the development and commercialization of therapies to aid in smoking cessation. The company’s lead product candidate is based on cytisinicline, a plant-based alkaloid that is being developed to help people quit smoking by reducing nicotine cravings and withdrawal symptoms. Achieve Life Sciences is engaged in clinical trials to advance its therapeutic offerings aimed at addressing nicotine addiction. The company is headquartered in Seattle, United States, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage